JoinTown Pharmaceutical Group Co., Ltd. a tech-driven full-chain pharmaceutical supply chain service provider based in the pharmaceutical circulation, logistics service, medical health, and other big health industries, specializes in five business fields, namely, pharmaceutical distribution and supply chain services, general agency sales and self-made business, digital retailing, digital logistics and supply chain solutions, and medical health and technology empowerment services. Since the successful listing on Shanghai Stock Exchange (Stock abbreviation: Jointown, Stock code: 600998) on 2 November 2010, Jointown has achieved continuous, stable, and high-quality development, and ranked the fourth among Chinese pharmaceutical business enterprises for years, taking the lead in the race among pharmaceutical business enterprises in China, and ranking the 93th place of Fortune 500 (China version) in 2021.
READ MOREJointown met its new development strategy period from year 2020 to 2022. The development theme of this strategic period is "Make professional pharmaceutical distribution, do excellent product marketing, provide innovative internet service and solidify high-quality development". Applied itself to the pharmaceuticals and big health industry, the company provides pharmaceutical institutions, retail pharmacies, commercial wholesale, production enterprises with professional pharmaceutical distribution, sole agency, modern logistics, information technology and other services.
READ MORE
